Global Information
회사소개 | 문의 | 비교리스트

세계의 비호지킨 림프종 치료제 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2019-2026년)

Global Non-Hodgkin Lymphoma Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

리서치사 Value Market Research
발행일 2020년 05월 상품 코드 935428
페이지 정보 영문 95 Pages
가격
US $ 2,100 ₩ 2,401,000 Data Pack (Single User License)
US $ 3,950 ₩ 4,516,000 PDF (Single User License)
US $ 4,950 ₩ 5,659,000 PDF (10-user License)
US $ 8,600 ₩ 9,833,000 PDF (Corporate User License)


세계의 비호지킨 림프종 치료제 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2019-2026년) Global Non-Hodgkin Lymphoma Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026
발행일 : 2020년 05월 페이지 정보 : 영문 95 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 비호지킨 림프종 치료제(Non-Hodgkin Lymphoma Therapeutics) 시장에 대해 조사 분석했으며, 시장 개요, 시장 규모와 예측, 부문별 시장 분석, 지역별 시장 분석, 경쟁 상황 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 서문

  • 보고서에 대해
  • 조사 범위
  • 조사 방법

제2장 주요 요약

  • 시장 개요
  • 시장 현황

제3장 업계 분석

  • 서론
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 동향
  • Porter's Five Forces 분석
  • 시장 매력 분석

제4장 밸류체인 분석

  • 밸류체인 분석
  • 원재료 분석
  • 잠재적인 바이어 리스트
  • 마케팅 채널

제5장 세계의 비호지킨 림프종 치료제 시장 분석 : 암 종류별

  • 개요
  • 시장 분석
  • 신경교종 시장 분석
  • 수막종 시장 분석
  • 뇌하수체선종 시장 분석
  • 신경초종 시장 분석
  • 수모세포종 시장 분석

제6장 세계의 비호지킨 림프종 치료제 시장 분석 : 치료별

  • 개요
  • 시장 분석
  • 방사선요법 시장 분석
  • 화학요법 시장 분석
  • 표적치료 시장 분석

제7장 세계의 비호지킨 림프종 치료제 시장 분석 : 지역별

  • 지역의 전망
  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제8장 기업 경쟁 상황

  • 시장 경쟁
  • 파트너십/협업/계약
  • 합병과 인수
  • 신제품 발매
  • 기타

제9장 기업 개요

  • 기업 점유율 분석
  • 시장 집중률
  • Bayer AG
  • Bristol Myers Squibb Co.
  • F. Hoffman La-Roche Ltd.
  • GlaxoSmithKline plc
  • Merck
  • Novartis
  • Pfizer
  • 기타

제10장 COVID-19 팬데믹의 영향 분석

  • 시장에서의 COVID-19 팬데믹의 영향 분석
    • 생산에 대한 직접적인 영향
    • 공급망과 시장의 혼란
    • 기업과 금융 시장에 대한 재정적 영향
  • COVID-19 생산, 수입, 수출 및 수요별 영향 분석
  • 프리, 포스트 COVID-19 시장
  • 시나리오별 2020년 시장 규모에 대한 코로나바이러스(COVID-19)의 영향 추정
  • COVID-19 : 시장의 미시적 및 거시적 요인 분석
KSM 20.06.08

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Glioma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Meningioma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Pituitary Adenoma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Schwannomas by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Medulloblastoma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Therapeutics (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Radiation Therapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Chemotherapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Targeted Therapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market by Geography (USD MN)
  • North America Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country (USD MN)
  • United State Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • United State Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Rest of North America Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Rest of North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Europe Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Europe Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • United Kingdom Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • United Kingdom Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • France Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • France Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Germany Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Germany Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country (USD MN)
  • China Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • China Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Japan Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Japan Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • India Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • India Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Rest of Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Latin America Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country (USD MN)
  • Brazil Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Brazil Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Rest of Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country (USD MN)
  • Middle East Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Middle East Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Africa Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Therapeutics (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019

LIST OF FIGURES

  • Research Scope of Non-Hodgkin Lymphoma Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Non-Hodgkin Lymphoma Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Therapeutics
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Glioma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Meningioma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Pituitary Adenoma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Schwannomas by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Medulloblastoma by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Therapeutics (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Radiation Therapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Chemotherapy by Geography (USD MN)
  • Global Non-Hodgkin Lymphoma Therapeutics Market Analysis in Targeted Therapy by Geography (USD MN)
  • Latin America Non-Hodgkin Lymphoma Therapeutics Market by Revenue
  • Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market by Revenue
  • Recent Development in Non-Hodgkin Lymphoma Therapeutics Industry
  • Company Market Share Analysis, 2019
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Value Market Research's latest report on the Global Non-Hodgkin Lymphoma Therapeutics Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2020-2026.

The global non-hodgkin lymphoma therapeutics market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global non-hodgkin lymphoma therapeutics market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global non-hodgkin lymphoma therapeutics market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global non-hodgkin lymphoma therapeutics market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global non-hodgkin lymphoma therapeutics market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global non-hodgkin lymphoma therapeutics market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global non-hodgkin lymphoma therapeutics market.

The market analysis involves a section exclusively to list the major players of the global non-hodgkin lymphoma therapeutics market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Non-Hodgkin Lymphoma Therapeutics Market Report Segments the market as below -

By Cancer Type

Glioma

Meningioma

Pituitary Adenoma

Schwannomas

Medulloblastoma

By Therapeutics

Radiation Therapy

Chemotherapy

Targeted Therapy

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Non-Hodgkin Lymphoma Therapeutics Market
  • 2.2. Global Non-Hodgkin Lymphoma Therapeutics Market Snapshot

3 . NON-HODGKIN LYMPHOMA THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.3. Market Restraints of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.4. Opportunities of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.5. Trends of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.6. Porter's Five Force Analysis of Non-Hodgkin Lymphoma Therapeutics Market
  • 3.7. Non-Hodgkin Lymphoma Therapeutics Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Cancer Type
    • 3.7.2 Market Attractive Analysis by Therapeutics
    • 3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Non-Hodgkin Lymphoma Therapeutics Value Chain Analysis
  • 4.2. Non-Hodgkin Lymphoma Therapeutics Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Non-Hodgkin Lymphoma Therapeutics Raw Material Manufactures List
    • 4.2.3. Price Trend of Non-Hodgkin Lymphoma Therapeutics Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL NON-HODGKIN LYMPHOMA THERAPEUTICS MARKET ANALYSIS BY CANCER TYPE

  • 5.1 Overview by Cancer Type
  • 5.2 Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Cancer Type
  • 5.3 Market Analysis of Glioma by Regions
  • 5.4 Market Analysis of Meningioma by Regions
  • 5.5 Market Analysis of Pituitary Adenoma by Regions
  • 5.6 Market Analysis of Schwannomas by Regions
  • 5.7 Market Analysis of Medulloblastoma by Regions

6 . GLOBAL NON-HODGKIN LYMPHOMA THERAPEUTICS MARKET ANALYSIS BY THERAPEUTICS

  • 6.1 Overview by Therapeutics
  • 6.2 Global Non-Hodgkin Lymphoma Therapeutics Market Analysis by Therapeutics
  • 6.3 Market Analysis of Radiation Therapy by Regions
  • 6.4 Market Analysis of Chemotherapy by Regions
  • 6.5 Market Analysis of Targeted Therapy by Regions

7 . GLOBAL NON-HODGKIN LYMPHOMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America
    • 7.3.1. Overview
    • 7.3.2. North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.3.3. North America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.3.4. United State
    • 7.3.5. Rest of North America
  • 7.4. Europe
    • 7.4.1. Overview
    • 7.4.2. Europe Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.4.3. Europe Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.4.4. United Kingdom
    • 7.4.5. France
    • 7.4.6. Germany
    • 7.4.7 Rest of Europe
  • 7.5. Asia Pacific
    • 7.5.1. Overview
    • 7.5.2. Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.5.3. Asia Pacific Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.5.4. China
    • 7.5.5. Japan
    • 7.5.6. India
    • 7.5.7. Rest of Asia Pacific
  • 7.6. Latin America
    • 7.6.1. Overview
    • 7.6.2. Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.6.3. Latin America Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.6.4. Brazil
    • 7.6.5. Rest of Latin America
  • 7.7. Middle East & Africa
    • 7.7.1. Overview
    • 7.7.2. Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Market Segment
    • 7.7.3. Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Estimate by Country
    • 7.7.4. Middle East
    • 7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE NON-HODGKIN LYMPHOMA THERAPEUTICS COMPANIES

  • 8.1. Non-Hodgkin Lymphoma Therapeutics Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF NON-HODGKIN LYMPHOMA THERAPEUTICS INDUSTRY

  • 9.1. Company Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Bayer AG
    • 9.3.1. Company Overview
    • 9.3.2. Financials
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Bristol Myers Squibb Co.
    • 9.4.1. Company Overview
    • 9.4.2. Financials
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. F. Hoffman La-Roche Ltd.
    • 9.5.1. Company Overview
    • 9.5.2. Financials
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. GlaxoSmithKline plc
    • 9.6.1. Company Overview
    • 9.6.2. Financials
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Merck
    • 9.7.1. Company Overview
    • 9.7.2. Financials
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Novartis
    • 9.8.1. Company Overview
    • 9.8.2. Financials
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Pfizer
    • 9.9.1. Company Overview
    • 9.9.2. Financials
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Others
    • 9.10.1. Company Overview
    • 9.10.2. Financials
    • 9.10.3. Products
    • 9.10.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 10.1. Impact Analysis of Covid-19 Outbreak on the Market
    • 10.1.1. Direct Impact on Production
    • 10.1.2. Supply Chain and Market Disruption
    • 10.1.3. Financial Impact on Firms and Financial Markets
  • 10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 10.3. Pre V/S Post COVID-19 Market
  • 10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
  • 10.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note: in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies.

Back to Top
전화 문의
F A Q